Traws Pharma, Inc.
USD1.42
-0.05 (-3.40%)
CEO
Iain D. Dukes
IPO Date
2013-07-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.46
Prev. Close
$1.47
Day Low
$1.40
Day High
$1.46
52W Low
$1.00
52W High
$3.27
Market Cap
$0.01B
Volume
0.26M
| 597,729 |
| $1.67 |
| 28 Apr 2026 | ORBIMED ADVISORS LLC | 10 percent owner | P-Purchase | Acquired | 1,793,187 | $1.67 |
| 8 Apr 2026 | Parker Charles Nolan | Chief Financial Officer | A-Award | Acquired | 15,393 | $0.00 |
| 8 Apr 2026 | Parker Charles Nolan | Chief Financial Officer | A-Award | Acquired | 32,406 | $3.01 |
| 8 Apr 2026 | Parker Charles Nolan | Chief Financial Officer | A-Award | Acquired | 61,571 | $2.33 |
| 8 Apr 2026 | Parker Charles Nolan | Chief Financial Officer | A-Award | Acquired | 104,544 | $1.60 |
| 8 Apr 2026 | Parker Charles Nolan | — | Disposed | 0 | $0.00 |
| 10 Mar 2026 | Clarke Trafford | director | A-Award | Acquired | 33,435 | $1.60 |
| 10 Mar 2026 | CAUTREELS WERNER | director | A-Award | Acquired | 31,258 | $1.60 |